Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. Ichikawa J, et al. Neuropsychopharmacology. 2002 Mar;26(3):325-39. doi: 10.1016/S0893-133X(01)00312-8. Neuropsychopharmacology. 2002. PMID: 11850147
Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
Li Z, Ichikawa J, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Eur J Pharmacol. 2004 Jun 16;493(1-3):75-83. doi: 10.1016/j.ejphar.2004.04.028. Eur J Pharmacol. 2004. PMID: 15189766
Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
Huang M, Li Z, Ichikawa J, Dai J, Meltzer HY. Huang M, et al. Among authors: ichikawa j. Brain Res. 2006 Jul 12;1099(1):44-55. doi: 10.1016/j.brainres.2006.04.081. Epub 2006 Jul 7. Brain Res. 2006. PMID: 16824491
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Psychopharmacology (Berl). 2005 Dec;183(2):144-53. doi: 10.1007/s00213-005-0170-9. Epub 2005 Nov 9. Psychopharmacology (Berl). 2005. PMID: 16220333
Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release.
Ichikawa J, Chung YC, Dai J, Meltzer HY. Ichikawa J, et al. Brain Res. 2005 Aug 2;1052(1):56-62. doi: 10.1016/j.brainres.2005.06.009. Brain Res. 2005. PMID: 16061211
Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Ichikawa J, Dai J, Meltzer HY. Ichikawa J, et al. Brain Res. 2005 Jul 12;1049(2):182-90. doi: 10.1016/j.brainres.2005.05.005. Brain Res. 2005. PMID: 15936730
N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
Li Z, Huang M, Ichikawa J, Dai J, Meltzer HY. Li Z, et al. Among authors: ichikawa j. Neuropsychopharmacology. 2005 Nov;30(11):1986-95. doi: 10.1038/sj.npp.1300768. Neuropsychopharmacology. 2005. PMID: 15900318
Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism.
Chung YC, Li Z, Dai J, Meltzer HY, Ichikawa J. Chung YC, et al. Among authors: ichikawa j. Brain Res. 2004 Oct 8;1023(1):54-63. doi: 10.1016/j.brainres.2004.07.009. Brain Res. 2004. PMID: 15364019
Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY, Li Z, Kaneda Y, Ichikawa J. Meltzer HY, et al. Among authors: ichikawa j. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. doi: 10.1016/j.pnpbp.2003.09.010. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 14642974 Review.
5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T, Meltzer HY, Ichikawa J. Kuroki T, et al. Among authors: ichikawa j. Brain Res. 2003 May 16;972(1-2):216-21. doi: 10.1016/s0006-8993(03)02516-2. Brain Res. 2003. PMID: 12711095
250 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback